DXL Board Urges Rejection of FullBeauty Share Issuance Ahead of Dec. 21 Vote
DXLG is trading near its 52-week low of $0.362 (10% above the low) on light trading volume (0.2× avg).
Summary
DXL's board unanimously recommends stockholders vote against issuing shares to fund the FullBeauty merger, arguing FullBeauty's results have deteriorated, its debt has risen, and it may even carry negative equity value. The board says the existing exchange terms could substantially dilute DXL holders. This follows the updated merger proxy filed Nov. 13 and the Delaware Chancery injunction that blocked DXL from terminating the deal. The stockholder vote on share issuance is set for Dec. 21, 2026 — that vote decides whether the transaction can proceed at all.
At the time of this announcement, DXLG was trading at $0.40 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $22.2M. The 52-week trading range was $0.36 to $1.58. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.